No Detail Found!

Cilomilast, a PDE4 Inhibitor, Suppresses CD4+ and CD8+ T Cell Proliferation in the Thymus and Spleen of Rats: Mechanism of Glutathione Reduction

Author(s)
Arzu Gezer Vocational School of Health Services, Atatürk University, Erzurum, Türkiye; Pharmaceutical Research and Development, Graduate School of Natural and Applied Sciences, Atatürk University, Erzurum/Türkiye
Nurcan Kılıç Baygutalp Department of Biochemistry, Faculty of Pharmacy, Atatürk University,Erzurum,Türkiye
Mustafa Cengiz Department of Elementary Education, Faculty of Education, Siirt University,Siirt,Türkiye
Bahri Gür Department of Biochemistry, Faculty of Pharmacy, Atatürk University,Erzurum,Türkiye
Mustafa Özkaraca Department of Pathology, Faculty of Veterinary Medicine, Cumhuriyet University,Sivas,Türkiye
Abstract
Cilomilast is an oral phosphodiesterase-4 (PDE4) inhibitor recommended for treating COPD. However, its side effects and low therapeutic index remain an unresolved problem in clinical practice. This study aimed to evaluate the effects of cilomilast on the spleen and thymus tissues of rats. For experimental studies, 24 male Sprague-Dawley rats weighing 200-220g were randomly divided into three experimental groups: The procedures were repeated for 7 days for the control, sham, and cilomilast groups. Blood and tissue samples were collected from the rats under anesthesia on day 8 of the experiment for analysis. p<0.05 at a 95% confidence level was considered to indicate statistical significance. Severe tissue damage in the thymus and spleen was observed in the cilomilast group. In the thymus and spleen tissues of the control and sham groups, CD4+ and CD8+ cell immunopositivity were more intense, while the density of these cells was significantly reduced in the cilomilast group. In addition, glutathione (GSH) levels decreased, and nitric oxide levels increased in both tissues of the cilomilast group. However, in-silico results showed that the decrease in GSH levels is due to the enzymes ?-glutamylcysteine synthase and glutathione synthase, which act as catalysts in the two-step GSH biosynthesis mechanism. Suppression of the immune system targets both harmful and compensatory pathways so that both beneficial mechanisms and pathological changes can be blocked. To eliminate these cilomilast-induced side effects and enable more effective clinical application, it may be recommended to develop formulations such as lipid-based inhaled forms or nano-drug delivery systems including dendrimers, reverse micelle systems, polymeric or lipid-based carriers as an alternative to conventional application.
Publication Details
Page(s) 707-714
Published Journal: Pakistan Veterinary Journal, Volume: 44, Issue: 3, Year: 2024

Request the full text from PASTIC

Keywords
Cilomilast CD4+, CD8+ In-silico modelling Spleen Thymus
References
Aydin M,Altintas N,Cem Mutlu L .2017 .Asymmetric dimethylarginine contributes to airway nitric oxide deficiency in patients with COPD. Clin Respir J, 11 : 318-327.
Barnes PJ .2020 .Oxidative stress-based therapeutics in COPD. Redox Biol, 33 : 101544.
Blauvelt A,Langley RG,Gordon KB .2023 .Next generation PDE4 inhibitors that selectively target PDE4B/D subtypes: a narrative review. Dermatol Ther, 13 : 3031-3042.
Can S,Çetik Yıldız S,Keskin C .2022 .Investigation into the protective effects of Hypericum Triquetrifolium Turra seed against cyclophosphamide-induced testicular injury in Sprague Dawley rats. Drug Chem Toxicol, 45 : 1679-1686.
Cengiz M,Gür B,Sezer CV .2023 .Alternations in interleukin-1β and nuclear factor kappa beta activity (NF-kB) in rat liver due to the co-exposure of Cadmium and Arsenic: Protective role of curcumin. Environ Toxicol Pharmacol, 102 : 104218.
Crocetti L,Floresta G,Cilibrizzi A,Giovannoni MP .2022 .An Overview of PDE4 Inhibitors in Clinical Trials: 2010 to Early 2022. , : .
Donato M,Tolosa L .2021 .High-Content Screening for the Detection of Drug-Induced Oxidative Stress in Liver Cells. Antioxidants (Basel) 10., : .
Fan T,Wang W,Wang Y .2024 .PDE4 inhibitors: potential protective effects in inflammation and vascular diseases. Front Pharmacol, 15 : 1407871.
Flemming S,Schlegel N,Wunder C .2014 .Phosphodiesterase 4 inhibition dose dependently stabilizes microvascular barrier functions and microcirculation in a rodent model of polymicrobial sepsis. Shock (Augusta, 41 : 537-545.
Gezer A,Karadağ SE .2023 .Investigation of apoptotic and autophagic effects of chronic roflumilast use on testicular tissue in rats by immunohistochemical and immunofluorescence methods. Iran J Basic Med Sci, 26 : 276-284.
Gür F,Ağgül AG,Gülaboğlu M .2020 .Su ile hazırlanan zeytin yaprağı özütünün ratlarda streptozotosin kaynaklı oksidatif stres ve lipit peroksidasyonu üzerine etkileri. J Ins Sci Technol, 10 : 2406-2415.
Gür F,Cengiz M,Gür B .2023 .Therapeutic role of boron on acrylamide-induced nephrotoxicity, cardiotoxicity, neurotoxicity, and testicular toxicity in rats: Effects on Nrf2/Keap-1 signaling pathway and oxidative stress. J Trace Elemen Med Biol, 80 : 127274.
He Y,Huang Y,Mai C .2020 .The immunomodulatory role of PDEs inhibitors in immune cells: Therapeutic implication in rheumatoid arthritis. Pharmacol Res, 161 : 105134.
Ismail M,Hossain MF,Tanu AR,Shekhar HU .2015 .Effect of spirulina intervention on oxidative stress, antioxidant status, and lipid profile in chronic obstructive pulmonary disease patients. Biomed Res Int, 486120 : .
Janjua S,Fortescue R,Poole P .2020 .Phosphodiesterase‐4 inhibitors for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 5., : .
Ju J,Li Z,Shi Q .2022 .Baicalin Inhibits Inflammation in Rats with Chronic Obstructive Pulmonary Disease by the TLR2/MYD88/NFκBp65 Signaling Pathway. Evid Based Complement Alternat Med 7273387., : .
Kim SY,An TJ,Rhee CK .2021 .The effect and associated mechanism of action of phosphodiesterase 4 (PDE4) inhibitor on CD4+ lymphocyte proliferation. Clin Exp Pharmacol Physiol, 48 : 221-226.
Lewis SM,Williams A,Eisenbarth SC .2019 .Structure and function of the immune system in the spleen. Sci Immunol, 4 : .
Liu X,Zhang H,Wang Y .2020 .Fractional Exhaled Nitric Oxide is Associated with the Severity of Stable COPD. Copd: Chronic Obstr Pulm Dis 17:(2), : 121-127.
Luo W,Long Y,Feng Z .2021 .A γ-glutamylcysteine ligase AcGCL alleviates cadmium-inhibited fructooligosaccharides metabolism by modulating glutathione level in Allium cepa L. J Hazard Mater, 419 : 126255.
Montrose D,Galluzzi L .2019 .Sulfur metabolism and its contrubition to malignancy. , : 39-83.
Nguyen HO,Tiberio L,Facchinetti F .2023 .Modulation of human dendritic cell functions by phosphodiesterase-4 inhibitors: potential relevance for the treatment of respiratory diseases. Pharmaceutics, 15 : 2254.
Phillips JE .2020 .Inhaled phosphodiesterase 4 (PDE4) inhibitors for inflammatory respiratory diseases. Front Pharmacol, 11 : 259.
Sahin B,Karabulut S,Filiz AK .2022 .protects against acetaminophen-induced hepatotoxicity in rats. Chem Biol Interact, 366 : 110119.
Strong VD .2014 .Molecular correlates of multiday memory in an appetitive conditioning model: insights into mediators of memory extension. PhD Thesis, : .
Szczypka M .2020 .Effects of selective PDE7 inhibitors and dual PDE4/7 inhibitors on T cell functions. Int J Mol Sci, 21 : 6118.
Xu J,Luo Y,Yuan C .2020 .Downregulation of nitric oxide collaborated with radiotherapy to promote anti-tumor immune response via inducing CD8+ T cell infiltration. Inter J Biol Sci, 16 : 1563.
Yang Y,Lenherr ED,Gromes R .2019 .Plant glutathione biosynthesis revisited: redox-mediated activation of glutamylcysteine ligase does not require homo-dimerization. Biochem J, 476 : 1191-1203.
Zhang C,Zhu W,Meng Q .2022 .Halotherapy relieves chronic obstructive pulmonary disease by alleviating NLRP3 inflammasome-mediated pyroptosis. Ann Transl Med, 10 : 1279.
0

Citations

0

Downloads

50

Views